ꢀ
Ortega-Jimenez et al.
156 Organometallics, Vol. 29, No. 1, 2010
Tricarbonyl-η4-[4,5-dimethylene-3-(4-methylphenyl)-1,3-oxa-
zolidin-2-one]iron(0) (6c). Following the general method, with
0.537 g of 3c and 2.92 g of Fe2(CO)9, 0.482 g (53%) of 6c was
obtained as a yellow-greenish solid: mp 123-124 °C; FT-IR
NMR (300 MHz, CDCl3) δ 0.23 (d, J = 5.2 Hz, 1H, H-7b), 1.28 (q,
J = 6.4 Hz, 1H, H-6), 1.82 (d, J = 5.2 Hz, 1H, H-7a), 1.83 (d, J =
6.4 Hz, 3H, CH3), 2.25 (s, 3H, CH3-Ar). Anal. Calcd for
C16H13NO5Fe: C, 54.11; H, 3.69; N, 3.94. Found: C, 54.11; H,
3.71; N, 4.02.
ν
max (KBr) 2054, 1980, 1964 [Fe(CO)3], 1783 (CdO) cm-1; 1H
NMR (300 MHz, CDCl3) δ 0.30 (d, J = 5.2 Hz, 1H, H-7b), 0.50
(d, J = 5.4 Hz, 1H, H-6b), 2.13 (d, J = 5.2 Hz, 1H, H-7a), 2.41
(s, 3H, CH3-Ar), 2.58 (d, J = 5.4 Hz, 1H, H-6a), 7.29-7.39 (m,
4H, H-9, H-10); 13C NMR (75.4 MHz, CDCl3) δ 20.2 (C-7),
21.2 (CH3-Ar), 22.2 (C-6), 111.6 (C-4), 122.7 (C-5), 125.3 (C-9),
130.1 (C-8), 130.5 (C-10), 139.0 (C-11), 154.9 (C-2), 206-209
[Fe(CO)3]; MS (70 eV) m/z 341 (Mþ, 1), 283 (2), 267 (14), 237
(1), 193 (3), 161 (33), 146 (35), 146 (35), 133 (10), 132(100), 91
(77), 65 (33), 38 (13). Anal. Calcd for C15H11NO5Fe: C, 52.82;
H, 3.25; N, 4.11. Found: C, 52.97; H, 3.16; N, 4.19.
Tricarbonyl-η4-[(Z)-5-ethylidene-4-methylene-3-(4-methylphenyl)-
1,3-oxazolidin-2-one]iron(0) (7c). Following the general method,
with 0.574 g of 4c and 2.92 g of Fe2(CO)9, 0.597 g (63%) of 7c
was obtained as a yellow solid: mp 102-103 °C; FT-IRνmax (KBr)
1
2042, 1980, 1960 [Fe(CO)3], 1770 (CdO) cm-1; H NMR (300
MHz, CDCl3) δ0.19 (d, J = 5.2 Hz, 1H, H-7b), 1.27 (q, J = 6.5 Hz,
1H, H-6), 1.83 (d, J=6.5Hz,3H,CH3),2.02(d,J= 5.2, 1H, H-7a),
2.41(s, 3H, CH3-Ar), 7.25-7.39 (m, 4H, H-9, H-10); 13CNMR(75.4
MHz, CDCl3) δ 13.8 (CH3), 18.6 (C-7), 21.1 (CH3-Ar), 38.7 (C-6),
108.1 (C-4), 123.2 (C-5), 125.3 (C-9), 130.1 (C-8), 130.5 (C-10), 138.9
(C-11), 154.8 (C-2), 206-209 [Fe(CO)3]; MS (70 eV) m/z 355 (Mþ,
2), 327 (3), 299 (26), 271 (100), 227 (1), 215 (4), 174 (16), 91 (11), 84
(5), 56 (15). Anal. Calcd for C16H13NO5Fe: C, 54.11; H, 3.69; N,
3.94. Found C, 54.23; H, 3.83; N, 3.96.
Tricarbonyl-η4-[3-(3-chlorophenyl)-4,5-dimethylene-1,3-oxa-
zolidin-2-one]iron(0) (6d). Following the general method, with
0.591 g of 3d and 2.92 g of Fe2(CO)9, 0.366 g (38%) of 6d was
obtained as a yellow solid: mp 110-111 °C; FT-IR νmax (film)
2049, 1976 [Fe(CO)3], 1782 (CdO) cm-1; 1H NMR (300 MHz,
CDCl3) δ 0.34 (d, J = 3.0 Hz, 1H, H-7b), 0.52 (d, J = 3.4 Hz,
1H, H-6b), 2.17 (d, J = 3.0 Hz, 1H, H-7a), 2.60 (d, J = 3.4 Hz,
1H, H-6a), 7.36-7.83 (m, 4H, H-9, H-11, H-12, H-13); 13C
NMR (75.4 MHz, CDCl3) δ 20.0 (C-7) 22.4 (C-6), 110.7 (C-4),
122.8 (C-5), 123.4 (C-13), 125.5 (C-9), 129.0 (C-11), 139.0 (C-
12), 133.9 (C-8), 135.5 (C-10), 154.2 (C-2), 206-209 [Fe(CO)3];
MS (70 eV) m/z 361 (Mþ, 2), 333 (7), 305 (55), 277 (100), 241
(38), 197 (40), 167 (17), 142 (28), 91 (19), 84 (41). Anal. Calcd
for C14H8ClNO5Fe: C, 46.51; H, 2.23; N, 3.87. Found: C,
46.75; H, 2.19; N, 3.70.
Tricarbonyl-η4-[(Z)-3-(3-chlorophenyl)-5-ethylidene-4-methy-
lene-1,3-oxazolidin-2-one]iron(0) (7d). Following the general
method, with 0.629 g of 4d and 2.92 g of Fe2(CO)9, 0.481 g
(48%) of 7d was obtained as yellow crystals: mp 161-162 °C;
FT-IR νmax (film) 2036, 1968 [Fe(CO)3], 1782 (CdO) cm-1; 1H
NMR (300 MHz, CDCl3) δ 0.22 (d, J = 5.3 Hz, 1H, H-7b), 1.29
(q, J = 6.5 Hz, 1H, H-6), 1.83 (d, J = 6.5 Hz, 3H, CH3), 2.07 (d,
J = 5.3 Hz, 1H, H-7a), 7.35-7.66 (m, 4H, H-9, H-11, H-12,
H-13); 13C NMR (75.4 MHz, CDCl3) δ 13.8 (CH3), 18.7 (C-7),
39.0 (C-6), 107.3 (C-4), 123.3 (C-5), 123.4 (C-13), 125.5 (C-9),
128.9 (C-11), 130.9 (C-12), 134.0 (C-8), 135.9 (C-10), 154.2
(C-2), 206-209 [Fe(CO)3]; MS (70 eV) m/z 375 (Mþ, 2), 347
(5), 319 (49), 291 (100), 255 (27), 211 (20), 155 (15), 111 (10), 84
(15). Anal. Calcd for C15H10ClNO5Fe: C, 47.97; H, 2.68; N,
3.73. Found: C, 47.77; H, 2.74; N, 3.76.
Tricarbonyl-η4-[3-(4-chlorophenyl)-4,5-dimethylene-1,3-oxazo-
lidin-2-one]iron(0) (6e). Following the general method, with 0.591
g of 3e and 2.92 g of Fe2(CO)9, 0.386 g (40%) of 6e was obtained
as a yellow solid: mp 107-109 °C; FT-IR νmax (KBr) 2054, 1976
Tricarbonyl-η4-[(Z)-3-(4-chlorophenyl)-5-ethylidene-4-methy-
lene-1,3-oxazolidin-2-one]iron(0) (7e). Following the general
method, with 0.629 g of 4e and 2.92 g of Fe2(CO)9, 0.36 g
(36%) of 7e was obtained as yellow crystals: mp 105-106 °C;
FT-IR νmax (KBr) 2050, 1972 [Fe(CO)3], 1780 (CdO) cm-1; 1H
NMR (300 MHz, CDCl3) δ 0.21 (d, J = 5.3 Hz, 1H, H-7b), 1.29
(q, J = 6.4 Hz, 1H, H-6), 1.83 (d, J = 6.4 Hz, 3H, CH3), 2.02 (d,
J = 5.3 Hz, 1H, H-7a), 7.43-7.50 (m, 4H, H-9, H-10); 13C NMR
(75.4 MHz, CDCl3) δ 13.8 (CH3), 18.5 (C-7), 39.0 (C-6), 107.4
(C-4), 123.3 (C-5), 126.6 (C-9), 130.1 (C-10), 131.4 (C-8), 134.5
(C-11), 154.3 (C-2), 206-209 [Fe(CO)3]; MS (70 eV) m/z 375
(Mþ, 2), 347 (4), 319 (30), 291 (100), 255 (3), 211 (4), 207 (11), 155
(6), 111 (9), 91 (10), 84 (18), 56 (34). Anal. Calcd for
C15H10ClNO5Fe: C, 47.97; H, 2.68; N, 3.73. Found: C, 48.09;
H, 2.88; N, 3.72.
1
[Fe(CO)3], 1786 (CdO) cm-1; H NMR (300 MHz, CDCl3) δ
0.32 (d, J = 5.3 Hz, 1H, H-7b), 0.51 (d, J = 5.4 Hz, 1H, H-6b),
2.13 (d, J = 5.3 Hz, 1H, H-7a), 2.60 (d, J = 5.4 Hz, 1H, H-6a),
7.41-7.52 (m, 4H, H-9, H-10); 13C NMR (75.4 MHz, CDCl3) δ
19.9 (C-7), 22.4 (C-6), 110.8 (C-4), 122.8 (C-5), 126.6 (C-9), 130.2
(C-10), 131.3 (C-8), 134.6 (C-11), 154.4 (C-2), 206-209
[Fe(CO)3]; MS (70 eV) m/z 361 (Mþ, 2), 333 (5), 305 (35), 277
(100), 241 (6), 197 (11), 167 (11), 142 (11), 91 (12), 84 (27), 56 (41).
Anal. Calcd for C14H8ClNO5Fe: C, 46.51; H, 2.23; N, 3.87.
Found: C, 46.34; H, 2.12; N, 3.86.
Tricarbonyl-η4-[(Z)-5-ethylidene-4-methylene-3-phenyl-1,3-oxa-
zolidin-2-one]iron(0) (7a). Following the general method, with
0.537 g of 4a and 2.92 g of Fe2(CO)9, 0.783 g (86%) of 7a was
obtained as yellow crystals: mp 163-164 °C; FT-IR νmax (KBr)
1
2050, 1970, 1964 [Fe(CO)3], 1782 (CdO) cm-1; H NMR (300
Tricarbonyl-η4-[(Z)-4-methylene-3-phenyl-5-propylidene-1,
3-oxazolidin-2-one]iron(0) (8a). Following the general meth-
od, with 0.574 g of 5a and 2.92 g of Fe2(CO)9, 0.549 g (58%) of
8a was obtained as a yellow solid: mp 126-127 °C; FT-IR
MHz, CDCl3) δ 0.20 (d, J = 5.2 Hz, 1H, H-7b), 1.27 (q, J = 6.4
Hz, 1H, H-6), 1.83 (d, J = 6.4 Hz, 3H, CH3), 2.05 (d, J = 5.2 Hz,
1H, H-7a), 7.39-7.57 (m, 5H, H-9, H-10, H-11); 13C NMR (75.4
MHz, CDCl3) δ 13.9 (CH3), 18.7 (C-7), 38.8 (C-6), 107.9 (C-4),
123.3 (C-5), 125.4 (C-9), 128.7 (C-11), 129.9 (C-10), 132.9 (C-8),
154.6 (C-2), 206-209 [Fe(CO)3]; MS (70 eV) m/z 201 (Mþ, 100),
186 (1), 156 (21), 142 (3), 118 (93), 104 (15), 77 (73), 65 (6). Anal.
Calcd for C15H11NO5Fe: C, 52.82; H, 3.25; N, 4.11. Found: C,
52.65; H, 3.05; N, 4.03.
ν
max (KBr) 2044, 1980, 1956 [Fe(CO)3], 1756 (CdO) cm-1; 1H
NMR (500 MHz, CDCl3) δ 0.20 (d, J = 5.2 Hz, 1H, H-7b),
1.17 (dd, J = 7.6, 6.8 Hz, 1H, H-6), 1.26 (t, J = 7.4 Hz, 3H,
CH3CH2), 2.06 (d, J = 5.2 Hz, 1H, H-7a), 2.03-2.13 (m, 1H,
CH3CH2), 2.24-3.34 (m, 1H, CH3CH2), 7.38-7.59 (m, 5H,
H-9, H-10, H-11); 13C NMR (125 MHz, CDCl3) δ 15.9
(CH3CH2), 18.8 (C-7), 22.5 (CH3CH2), 47.6 (C-6), 107.9 (C-
4), 122.5 (C-5), 125.4 (C-9), 128.7 (C-11), 129.9 (C-10), 132.9
(C-8), 154.7 (C-2), 207-209 [Fe(CO)3]; MS (70 eV) m/z 215
(Mþ, 65), 170 (5), 156 (4), 129 (4), 118 (100), 77 (48), 51 (20).
Anal. Calcd for C16H13NO5Fe: C, 54.11; H, 3.69; N, 3.94.
Found: C, 53.90; H, 4.00; N, 3.85.
Tricarbonyl-η4-[(Z)-5-ethylidene-4-methylene-3-(2-methylphenyl)-
1,3-oxazolidin-2-one]iron(0) (7b). Following the general method,
with 0.574 g of 4b and 2.92 g of Fe2(CO)9, 0.407 g (43%) of 7b as
a mixture of atropoisomers (63:37) was obtained as a yellow solid:
mp 158-160 °C; FT-IR νmax (KBr) 2049, 1973 [Fe(CO)3], 1766
(CdO) cm-1; 1H NMR (300 MHz, CDCl3) δ 0.19 (d, J = 5.1 Hz,
1H, H-7b), 1.27 (q, J = 6.4 Hz, 1H, H-6), 1.78 (d, J = 5.1 Hz, 1H,
H-7a), 1.84 (d, J = 6.4 Hz, 3H, CH3), 2.37 (s, 3H, CH3-Ar),
7.26-7.43 (m, 4H, H-10, H-11, H-12, H-13); 13C NMR (75.4 MHz,
CDCl3) δ 13.8 (CH3), 18.7 (C-7), 38.7 (C-6), 107.9 (C-4), 123.3
(C-5), 124.3, 128.3, 128.7, 129.8, 131.1 (C-8), 132.8 (C-9), 154.6 (C-
2), 208-209 [Fe(CO)3]. Signals attributed to the minor isomer: 1H
Tricarbonyl-η4-[(Z)-4-methylene-3-(2-methylphenyl)-5-propy-
lidene-1,3-oxazolidin-2-one]iron(0) (8b). Following the general
method, with 0.611 g of 5b and 2.92 g of Fe2(CO)9, 0.472 g (48%)
of 8b as a mixture of atropoisomers (62:38) was obtained
as yellow crystals: mp 113-115 °C; FT-IR νmax (film) 2047,